Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
The nutritional, cardiovascular and immunological effect of daily subcutaneous ghrelin in dialysis patients with evidence of malnutrition
Source of recordUK Trials
ISRCTNISRCTN43319045
Date ISRCTN assigned22/06/2006
Local reference number(s)N/A
Public titleThe nutritional, cardiovascular and immunological effect of daily subcutaneous ghrelin in dialysis patients with evidence of malnutrition
Scientific title
AcronymN/A
Disease/condition/study domainMalnutrition or renal failure
Study hypothesisGhrelin treatment has beneficial effects on the disordered nutritional, cardiovascular and immunological physiology of dialysis patients.
Design/methodologyRandomised, double-blind, placebo-controlled, crossover trial
Research ethics reviewApproved by the Riverside Research Ethics Committee on 01/02/2006, reference number: 05/Q0401/132
Countries of trialUnited Kingdom
Participants - inclusion criteriaDialysis patients at West London Renal and Transplant Centre, Hammersmith Hospital with evidence of malnutrition
Participants - exclusion criteria1. Anaemia
2. Over 75 years of age
3. Recent illness
Patient information material
Anticipated start date13/03/2006
Anticipated end date01/12/2006
Status of trialCompleted
Target number of participants20
InterventionsSubcutaneous ghrelin versus placebo
Primary outcome measure(s)1. Blood pressure
2. Energy expenditure
3. Cytokine production
Secondary outcome measure(s)1. Food intake
2. Nutritional parameters
Sources of fundingHammersmith Hospital NHS Trust (UK)
Sponsor nameHammersmith Hospitals NHS Trust (UK)
Sponsor detailsDu Cane Road
London
United Kingdom
W12 0HS
Sponsor websitehttp://www.hhnt.org/trust/index.htm
Contact nameDr Peter Choi
Contact detailsWest London Renal and Transplant Centre
Hammersmith Hospital
Du Cane Road
London
United Kingdom
W12 0HS
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN43319045
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central